UNSPSC 51284703: Cloxiqine or cloxyquin

This classification denotes an anti-infective agent with the molecular formula C9H6ClNO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier BPF36H1G6S, chemically known as 8-quinolinol, 5-chloro- but generally known as cloxiquine, which bears US NIH Compound Identifier 2817. European Medicines Agency schedules Cloxiquine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06784MIG.

The term CLOXIQUINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 28, No. 10 1974, List 14). CLOXIQUINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Cloxiqine or cloxyquin bears US NLM identifiers UMLS ID C0772059 and NCI Concept Code C61689. SMILES: C1=CC2=C(C=CC(=C2N=C1)O)CL.

UNSPSC 51284703 Cloxiqine or cloxyquin is a Commodity code that covers antimicrobial pharmaceutical products used in public health and emergency response. The recent solicitations tagged under this code, however, show limited direct alignment with the nominal product scope — state and local opportunities posted under this code have actually requested doxycycline hyclate, ciprofloxacin hydrochloride, naloxone, and drug deactivation systems for public health supply chains and community health initiatives. State and local issuing bodies under this code include state departments of public health, county health authorities, and regional emergency response organizations. The Illinois Department of Public Health and Seminole County, Florida have posted recent activity, reflecting use by both state-level and county-level health agencies for pharmaceutical procurement.

Geographic activity centers on Illinois and Florida based on recent postings. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical warehouse contract through the MMCAP Infuse consortium to Chartwell Rx LLC on August 28, 2026, via an Invitation for Bid (IFB) process for doxycycline hyclate 100mg tablets and ciprofloxacin hydrochloride 500mg tablets over a three-year term with 12-month initial period and two renewal years. Seminole County, Florida posted an IFB 60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building; the response deadline was July 26, 2023. The code shows limited recent state and local procurement volume and a mismatch between the code's nominal pharmaceutical name and the diverse antimicrobial and emergency-response products actually being solicited.